Regenerative Medicine Overview
Regenerative medicine treatments offered at Minnesota Regenerative Medicine include autologous (patient-derived) bone marrow aspirate concentrate (BMAC), fat aspirate concentrate (FAC), and platelet-rich plasma (PRP). These regenerative medicine treatments use surplus biocellular agents that are harvested from a patient’s bone marrow, fat tissue, and whole blood to isolate BMAC, FAC, and PRP, respectively. These biocellular agents are then injected back into the body at targeted locations within skin, soft tissue, and musculoskeletal tissue to initiate the natural process of tissue rejuvenation and regeneration.
At Minnesota Regenerative Medicine, areas in need of healing or rejuvenation are injected with BMAC, FAC, or PRP, or a combination of the three, depending on patient preference, physician recommendation, and the extent and repair needs of the underlying degenerative condition. Small needles are used to inject these biocellular agents from an area of surplus and reserve (bone marrow, fat tissue, and whole blood), to an area of exhaustion and depletion (degenerative or injured tissue sites).
For degenerative skin, soft tissue, or musculoskeletal conditions, Minnesota Regenerative Medicine is one of only a few clinics in Minnesota to offer patients BMAC, FAC, and PRP treatments to promote pain relief and healing of degenerative conditions. Since May of 2011, regenerative medicine specialists at Minnesota Regenerative Medicine have isolated and injected autologous (patient-derived) BMAC, FAC, or PRP into hundreds of patients to treat degenerative skin, soft tissue and musculoskeletal conditions.
While autologous BMAC, FAC, and PRP treatments have been used for decades to treat a variety of degenerative conditions, their clinical application in treating skin, soft tissue, and musculoskeletal conditions is relatively new, yet expanding. Research suggests that BMAC, FAC, and PRP treatments may slow the progression of osteoarthritis and deliver faster recovery of tendon and ligament injuries, with no adverse reactions. BMAC, FAC, and PRP treatments at MRM are for suitable candidates only, those which are cancer-free (for at least five years to be considered for BMAC or FAC), are in reasonably good health, and preferably under the age of 80. BMAC, FAC, and PRP treatments are presently not a covered benefit of Medicare or private insurance.
Our regenerative medicine specialist provides a complimentary consult for each patient to establish if they are a good candidate for an autologous biocellular treatment with BMAC, FAC, and PRP based on selection criteria, clinical indication, and desired treatment results.